NCT06081517

Evaluating Disparities in Precision Oncology

Evaluating Disparities in Precision Oncology: An Observational Trial in the Context of a Real-World Academic Practice Model

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 10,600 (estimated)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a non-randomized observational trial designed to collect detailed clinical, social determinant, and genomic data from patients enrolled in molecular oncology tumor boards across four comprehensive cancer centers.

Detailed description

This study proposes an innovative approach leveraging the molecular tumor boards across four comprehensive cancer centers, where real- world, diverse patients with metastatic cancer are seen receiving a broad scope of therapies in the context of precision medicine. The study plans to collect detailed clinical, social, and genomic data from patients to identify significant contributors of disparate survival and toxicity outcomes for patients with metastatic cancer.

Conditions

• Metastatic Cancer
• Advanced Cancer

Interventions

Type	Name	Description
BEHAVIORAL	Social Determinants of Health and toxicity questionnaires	Collect detailed clinical, and social data from patients to identify significant contributors of disparate survival and toxicity outcomes.

Timeline

• Start date: 2024-01-26
• Primary completion: 2028-12-01
• Completion: 2028-12-01
• First posted: 2023-10-13
• Last updated: 2025-06-13

Locations

1 site across 1 country: United States